News

This approval will enable a Phase Ib study of triphendiol in combination with gemcitabine in patients with unresectable, locally advanced or metastatic pancreatic and bile duct cancers. Triphendiol

Prior to Auspex, Mr Grey was president and CEO of SGX Pharmaceuticals, which was recently acquired by Eli Lilly. Prior to joining SGX, Mr Grey was president and

Stuart Randle, CEO of GI Dynamics, said: “We are very pleased to announce that we have received both the ISO certification and the CE mark approval, which are

According to the company, an application for sales approval will be submitted shortly and the sales of the product will begin at the end of the second quarter

Mr Truitt, who joins Achillion from ViroPharma, which recently acquired Lev Pharmaceuticals, will be responsible for identifying, evaluating and executing corporate partnerships, strategic initiatives and new product opportunities.

Under the terms of the agreement, Liquidia will provide Abbott with certain rights to Print technology for the development and commercialization of siRNA therapeutics. Financial terms were not

The company has hired over half of its 270-person field force which will promote Moxatag, said to be the first and only FDA-approved once-daily amoxicillin, to health care

The first national launch of Lodotra is expected to take place in first half of 2009 in Germany by Merck KGaA, Nitec’s partner for that region. SkyePharma will

Mr Moch has served as the president of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies, since early 2008. Mr Moch was previously